Known targets — ChEMBL curated mechanism
rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Stearic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.71 |
| ▸ | PPARG | P37231 | 7/20 | 0.71 |
| ▸ | PPARD | Q03181 | 7/20 | 0.71 |
| ▸ | PPARA | Q07869 | 7/20 | 0.71 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.71 |
| ▸ | TSHR | P16473 | 4/20 | 0.71 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.71 |
| ▸ | FABP4 | P15090 | 3/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | TLR2 | O60603 | 2/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.71 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.71 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.71 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.71 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | ESR1 | P03372 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Stearic Acid SCHEMBL8658083 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Octanoic Acid SCHEMBL16736954 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Dodecanoate SCHEMBL709152 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Decanoic Acid SCHEMBL629795 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Decanoic Acid SCHEMBL6721200 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Palmitic Acid SCHEMBL17075370 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Tridecanoate SCHEMBL16266603 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Dodecanoate SCHEMBL17075372 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Stearic Acid SCHEMBL7858318 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| Behenic Acid SCHEMBL22687520 | 1.00 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5795695-A | PHOTO-QUALITY RECORDING | XEROX CORPORATION (US) | 1998-08-18 | — | — | US | claimed |
| EP-4373526-A1 | COMPOSITIONS AND USES OF TRIGLYCERIDE MIMETICS TO TARGET SELECTIVELY MICROBIAL LIPASE | Excella Bioscientific Ltd (IL) | 2024-05-29 | — | — | EP | disclosed |
| WO-2023238058-A1 | OLEANOLIC ACID COMPOSITIONS FOR SEBUM CONTROL | Dyson Operations PTE. LTD. (SG) | 2023-12-14 | — | — | WO | disclosed |
| WO-2023238056-A1 | COMPOSITIONS FOR SEBUM CONTROL | Dyson Operations PTE. LTD. (SG) | 2023-12-14 | — | — | WO | disclosed |
| WO-2023220097-A1 | ORGANIC RICINOLEATE SALTS AS DEODORIZING AGENTS | COLONIAL CHEMICAL, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023119230-A1 | COAGULATION PATHWAY AND NICOTINAMIDE-ADENINE DINUCLEOTIDE PATHWAY MODULATING COMPOSITIONS AND METHODS OF THEIR USE | L'OREAL (FR) | 2023-06-29 | — | — | WO | disclosed |
| CN-110300571-B | Oil-in-water emulsions comprising specific surfactant systems | 莱雅公司 | 2023-04-28 | — | — | CN | disclosed |
| WO-2023002481-A1 | COMPOSITIONS AND USES OF TRIGLYCERIDE MIMETICS TO TARGET SELECTIVELY MICROBIAL LIPASE | EXCELLA BIOSCIENTIFIC LTD (IL) | 2023-01-26 | — | — | WO | disclosed |
| WO-2022066936-A1 | SYSTEMS FOR RETAINING POTENCY IN AN INFUSED BEVERAGE | VERTOSA INC. (US) | 2022-03-31 | — | — | WO | disclosed |
| US-20220087289-A1 | SYSTEMS FOR RETAINING POTENCY IN AN INFUSED BEVERAGE | VERTOSA INC. | 2022-03-24 | — | — | US | disclosed |
| CN-1512867-A | Cosmetic compositions containing dispersion polymers | �̵°��ɶ��ƹ�˾ | 2004-07-14 | — | — | CN | disclosed |
| EP-1383462-A4 | COSMETIC COMPOSITIONS CONTAINING DISPERSION POLYMERS | ONDEO NALCO CO (US) | 2004-07-07 | — | — | EP | disclosed |
| WO-2004043412-A1 | WATER SOLUBLE MONOMERS AND POLYMERS FOR PROTECTING SUBTRATES FROM ULTRAVIOLET LIGHT | NALCO COMPANY (US) | 2004-05-27 | — | — | WO | disclosed |
| US-6696067-B2 | FOR TREATING HAIR, SKIN OR NAILS, COMPRISES AN AQUEOUS SALT SOLUTION OF A CATIONIC, ANIONIC OR NONIONIC POLYMER OF GIVEN WEIGHT AVERAGE MOLECULAR WEIGHT, FOR EXAMPLE A COPOLYMER OF ACRYLAMIDE AND DIALLYLDIMETHYLAMMONIUM CHLORIDE | ONDEO NALCO COMPANY | 2004-02-24 | — | — | US | disclosed |
| EP-1383462-A1 | COSMETIC COMPOSITIONS CONTAINING DISPERSION POLYMERS | Ondeo Nalco Company (US) | 2004-01-28 | — | — | EP | disclosed |
| EP-1334717-A2 | Pharmaceutical Compositions For Oral And Topical Administration | IVAX Pharmaceuticals s.r.o. (CZ) | 2003-08-13 | — | — | EP | disclosed |
| US-20030059382-A1 | Cosmetic compositions containing dispersion polymers | ECOLAB USA INC. | 2003-03-27 | — | — | US | disclosed |
| WO-2002083085-A1 | COSMETIC COMPOSITIONS CONTAINING DISPERSION POLYMERS | ONDEO NALCO COMPANY (US) | 2002-10-24 | — | — | WO | disclosed |
| EP-1210119-A1 | PHARMACEUTICAL COMPOSITIONS FOR ORAL AND TOPICAL ADMINISTRATION | GALENA, A.S. (CZ) | 2002-06-05 | — | — | EP | disclosed |
| WO-2001012229-A1 | PHARMACEUTICAL COMPOSITIONS FOR ORAL AND TOPICAL ADMINISTRATION | IVAX-CR A.S. (CZ) | 2001-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030059382-A1 | Cosmetic compositions containing dispersion polymers | POLR1C, NACA, TYR | GPR84 4654/4885PPARG 933/4885PPARD 686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.